Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Combo Product Sponsors Convince US FDA To Change Postmarket Reporting Rule

Executive Summary

Final reg includes several clarifications about its scope and definitions, and also includes some additional reporting requirements.

You may also be interested in...



More Guidance Coming On Common Combo Product Designation Mistakes

US FDA's Office of Combination Products hopes Q&A guidance will help lower high refusal rate on requests for designation.

Common Combo Product Designation Mistakes To Be Outlined In Upcoming Guidance

US FDA's Office of Combination Products hopes Q&A guidance will help lower high refusal rate on requests for designation.

Combination Products: US FDA Extends Safety-Reporting Deadline

After major post-market safety reporting rule in 2016, guidance adds context for companies developing combination products. FDA also extends compliance deadlines in many cases until 2019.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS119703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel